Low stent thrombosis risk with the XIENCE V® Everolimus-Eluting Coronary Stent: evidence from randomized and single-arm clinical trials.
about
Stent thrombosis: an overview.The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view.Incidence and predictors of early and late target lesion revascularization after everolimus-eluting stent implantation in unselected patients in japan.Drug-eluting stents versus bare metal stents in ST elevation myocardial infarction at a follow-up of three years or longer: A meta-analysis of randomized trials.One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study.
P2860
Low stent thrombosis risk with the XIENCE V® Everolimus-Eluting Coronary Stent: evidence from randomized and single-arm clinical trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Low stent thrombosis risk with ...... nd single-arm clinical trials.
@en
Low stent thrombosis risk with ...... nd single-arm clinical trials.
@nl
type
label
Low stent thrombosis risk with ...... nd single-arm clinical trials.
@en
Low stent thrombosis risk with ...... nd single-arm clinical trials.
@nl
prefLabel
Low stent thrombosis risk with ...... nd single-arm clinical trials.
@en
Low stent thrombosis risk with ...... nd single-arm clinical trials.
@nl
P2093
P2860
P1476
Low stent thrombosis risk with ...... nd single-arm clinical trials.
@en
P2093
Alexandra Lansky
James Hermiller
Krishnakutty Sudhir
Kyoko Hattori
Manejeh Yaqub
Poornima Sood
Sherry Cao
Susan Bezenek
P2860
P304
P356
10.1111/J.1540-8183.2011.00628.X
P577
2011-03-28T00:00:00Z